# Pharmacodynamic Differences Between Branded and Unbranded Remifentanil Molecules

> **NCT02048293** · PHASE4 · COMPLETED · sponsor: **Fundación Universitaria de Ciencias de la Salud** · enrollment: 90 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Remifentanyl, Ultiva®
- **DRUG:** Remifentanil Laboratorios Chalver de Colombia S.A.
- **DRUG:** Fada Remifentanilo

## Key facts

- **NCT ID:** NCT02048293
- **Lead sponsor:** Fundación Universitaria de Ciencias de la Salud
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-10
- **Final completion:** 2013-12
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2014-01-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02048293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02048293, "Pharmacodynamic Differences Between Branded and Unbranded Remifentanil Molecules". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02048293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*